• 尊龙凯时

    Partner with us

    MILESTONE: Ailux enters into an AI licensing agreement with UCB for biologics discovery

    Illuminating Biologics Discovery with AI

    Scroll and explore

    PURPOSE

    Ailux represents a groundbreaking approach that synergizes the strengths of AI, wet lab, and proprietary data to drive biologics discovery.

    Our AI-powered platforms empower partners to achieve greater R&D success on the path toward the clinic.

    VIRTUAL TOUR

     Technology

    World-leading biologics AI models powered by a massive, proprietary biologics dataset

    EXPLORE OUR TECHNOLOGY
    • 01 AI ENGINES
    • 02 WET LAB
    • 03 DATABASE
    • Model

      protein complex structures to inform candidate selection and engineering.

    • Generate

      developable biologics sequences with specified profile.

    • Predict

      key properties to prioritize candidates without making them.

    A state-of-the-art wet lab underpins our advanced AI models and one-stop solutions for partners.

    Proprietary biologics database tailor-made for AI

    AtlaX

    Public dataset

    Data size

    Granularity

    Label-Free
    Qualitative
    Quantitative

    Seq

    Binder

    Develop-ability

    KD

    Epitope

    Trend line

    Bubble size proportional to cost of data


    • Model protein complex structures to inform candidate selection and engineering.

    • Generate developable biologics sequences with specified profile.

    • Predict key properties to prioritize candidates without making them.


    A state-of-the-art wet lab underpins our advanced AI models and one-stop solutions for partners.


    Proprietary biologics database tailor-made for AI

    AtlaX

    Public dataset

    Data size

    Granularity

    Label-Free
    Qualitative
    Quantitative

    Seq

    Binder

    Develop-ability

    KD

    Epitope

    Trend line

    Bubble size proportional to cost of data

    APPLICATIONS

    Addressing key bottlenecks in biologics discovery

    HOW WE DELIVER VALUE
    news & events

    Explore our upcoming news & events

    January 9, 2025

    UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform

    December 20, 2024

    AET US 2024 | Trilux Antibody Discovery, Hit Expansion, and Affinity Modulation via Active Learning

    November 21, 2024

    PEGS Europe 2024 | AI-Powered Integrated Antibody Discovery and Multi-Objective Engineering

    PARTNERSHIP

    Are you ready to push the boundaries of what’s possible? We are here to help you tackle difficult targets and optimize critical leads

    Partner with us
    ailux xtalpi
    Case Study

    Tapping into a greater search space for more quality hits using AI.

    Immune Repertoire Analysis

    In silico screening of millions of antibody sequences in the immune repertoire 

    K+
    VL Clonotypes
    K+
    VH Clonotypes
    Animals
    NCS Datasets
    M+
    Unique VL Sequences
    M+
    Unique VH Sequences
    Results and Insights

    XploreSeqTM Identifies Hits with High Accuracy

    XploreSeqTM routinely sequences millions of BCRs and identifies hits with high confidence (see figure). In this project, XploreSeq predicted 717 binders, from which 48 were randomly chosen for expression and testing. 66.7% (32/48) were confirmed to be binders, and only 18.6% (6/32) binders overlap with hybridoma hits.

    Read more case studies

    Subscribe to our newsletter

    Name(Required)
    This field is for validation purposes and should be left unchanged.
    Contact via Mail

    ab.bd@51-jiehun.com

    Office Building icon

    100 Chestnut Street, Somerville, MA 02143

    LinkedIn logo icon

    LinkedIn

    Explore

    © 2025 Ailux. All rights reserved.

    Privacy Settings
    We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
    Youtube
    Consent to display content from - Youtube
    Vimeo
    Consent to display content from - Vimeo
    Google Maps
    Consent to display content from - Google
    Spotify
    Consent to display content from - Spotify
    Sound Cloud
    Consent to display content from - Sound